Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

05/08/2019 07:30

Aug 5 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.43                4.28             17.40    
                 (+3.5 pct)          (-2.3 pct)       (+2.0 pct)  
  Operating        267 mln             95 mln           824 mln   
                (+179.1 pct)         (-65.5 pct)      (+1.1 pct)  
  Recurring        271 mln             107 mln          845 mln   
                (+152.7 pct)         (-62.7 pct)      (+4.0 pct)  
  Net              179 mln             65 mln           552 mln   
                (+172.9 pct)         (-65.7 pct)      (+5.6 pct)  
  EPS             52.56 yen           19.04 yen       161.45 yen  
  Ann Div                             10.00 yen        10.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T